비교리스트

 카트 문의
시장보고서
상품코드
1390402

세계의 인크레틴 관련 의약품 시장 : 의약품 유형별, 투여 경로별, 적응증별, 지역별, 국가별 분석 - 시장 인사이트 및 전망

Global Incretin Based Drugs Market : Analysis By Drug Type, Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast
발행일: | 리서치사: Azoth Analytics | 페이지 정보: 영문 230 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 인크레틴 관련 의약품 시장 규모는 2022년 407억 2,000만 달러에서 2029년 말까지 642억 8,000만 달러에 달할 것으로 예상되며, 예측 기간인 2024년부터 2029년까지 CAGR 6.8%를 나타낼 것으로 예상됩니다.

세계적으로 2형 당뇨병의 유병률 증가는 인크레틴 관련 약품 수요에 큰 영향을 미치고 있습니다. 당뇨병 유병률 증가는 좌식 생활습관, 식습관의 변화, 고령화 등 다양한 요인에 기인합니다.

다른 많은 항고혈당제와 비교했을 때, 인크레틴 관련 약물은 저혈당이나 체중 증가의 위험이 없는 등 몇 가지 주목할 만한 이점이 있으며, DPP4I와 GLP-1RA는 고유한 효능과 내약성 프로파일을 보여주기 때문에 의사는 환자의 질병 상태(HbA1c의 백분율로 표시됨) HbA1c의 백분율로 표시됨), 체중, 자가 주사제에 대한 환자의 선호도 등을 고려하여 각 환자에게 가장 적합한 약물을 선택할 수 있습니다. 블록버스터 의약품이 제네릭으로 출시되고, 투여 횟수를 줄인 개선된 제제가 등장함에 따라 인크레틴 관련 약품 수요는 크게 증가할 것으로 예상됩니다.

이 보고서는 세계 인크레틴 관련 의약품 시장에 대해 조사했으며, 시장 규모와 예측, 지역 및 부문 분석, 주요 동향과 기회 등의 정보를 전해드립니다.

목차

제1장 시장 배경

  • 범위와 제품 전망
  • 주요 요약
  • 조사 방법

제2장 전략적 추천 사항

제3장 세계의의 인크레틴 관련 의약품 시장 : 실적과 예측(2018년-2028년)

  • 세계의 비만 통계(2022년)
  • 인크레틴 관련 의약품 파이프라인 분석
  • 세계에서 가장 당뇨병 유병률이 높은 국가(2021년)
  • 세계의 당뇨병 환자 추정 인원수(2000년-2014년 E)
  • 세계의 인크레틴 관련 의약품 시장 : 대시보드
  • 세계의 인크레틴 관련 의약품 시장 : 시장 매출 평가(2018년-2028년)
  • 세계 인크레틴 관련 의약품 시장에 대한 COVID-19의 영향
  • 세계의 인크레틴 관련 의약품 시장 세분화 : 의약품 유형별
    • 세계의 인크레틴 관련 의약품 시장 : 의약품 유형별, 개요
    • 세계의 인크레틴 관련 의약품 시장 규모, 글루카곤 유사 펩티드-1 수용체 작용제(금액)(2018년-2028년)
    • 세계의 인크레틴 관련 의약품 시장 규모, 지Dipeptidyl Peptidase-4 억제제(금액)(2018년-2028년)
  • 세계의 인크레틴 관련 의약품 시장 세분화 : 투여 경로별
    • 세계의 인크레틴 관련 의약품 시장 : 투여 경로별, 개요
    • 세계의 인크레틴 관련 의약품 시장 규모, 경구(금액)(2018년-2028년)
    • 세계의 인크레틴 관련 의약품 시장 규모, 주사(금액)(2018년-2028년)
  • 세계의 인크레틴 관련 의약품 시장 세분화 : 적응증별
    • 세계의 인크레틴 관련 의약품 시장 : 적응증별, 개요
    • 세계의 인크레틴 관련 의약품 시장 규모, 당뇨병(금액)(2018년-2028년)
    • 세계의 인크레틴 관련 의약품 시장 규모, 비만(금액)(2018년-2028년)

제4장 세계의 인크레틴 관련 의약품 시장, 지역 분석

  • 조사 지역의 범위
  • 지역 현황

제5장 아메리카의 인크레틴 관련 의약품 시장 : 실적과 예측(2018년-2028년)

  • 아메리카의 인크레틴 관련 의약품 시장 : 현황
  • 아메리카의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
  • 아메리카의 인크레틴 관련 의약품 시장 : 주요 요인
  • 아메리카의 인크레틴 관련 의약품 시장 : 부문 분석
  • 아메리카의 인크레틴 관련 의약품 시장 세분화 : 의약품 유형별
  • 아메리카의 인크레틴 관련 의약품 시장 세분화 : 투여 경로별
  • 아메리카의 인크레틴 관련 의약품 시장 세분화 : 적응증별
  • 아메리카의 인크레틴 관련 의약품 시장 세분화 : 국가별
    • 미국의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 캐나다의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 기타 아메리카의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)

제6장 유럽의 인크레틴 관련 의약품 시장 : 실적과 예측(2018년-2028년)

  • 유럽의 인크레틴 관련 의약품 시장 : 현황
  • 유럽의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
  • 유럽의 인크레틴 관련 의약품 시장 : 주요 요인
  • 유럽의 인크레틴 관련 의약품 시장 : 부문 분석
  • 유럽의 인크레틴 관련 의약품 시장 세분화 : 의약품 유형별
  • 유럽의 인크레틴 관련 의약품 시장 세분화 : 투여 경로별
  • 유럽의 인크레틴 관련 의약품 시장 세분화 : 적응증별
  • 유럽의 인크레틴 관련 의약품 시장 세분화 : 국가별
    • 독일의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 영국의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 프랑스의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 이탈리아의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 스페인의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 기타 유럽의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)

제7장 아시아태평양의 인크레틴 관련 의약품 시장 : 실적과 예측(2018년-2028년)

  • 아시아태평양의 인크레틴 관련 의약품 시장 : 현황
  • 아시아태평양의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
  • 아시아태평양의 인크레틴 관련 의약품 시장 : 주요 요인
  • 아시아태평양의 인크레틴 관련 의약품 시장 : 부문 분석
  • 아시아태평양의 인크레틴 관련 의약품 시장 세분화 : 의약품 유형별
  • 아시아태평양의 인크레틴 관련 의약품 시장 세분화 : 투여 경로별
  • 아시아태평양의 인크레틴 관련 의약품 시장 세분화 : 적응증별
  • 아시아태평양의 인크레틴 관련 의약품 시장 세분화 : 국가별
    • 중국의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 일본의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 인도의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
    • 기타 아시아태평양의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)

제8장 중동 및 아프리카의 인크레틴 관련 의약품 시장 : 실적과 예측(2018년-2028년)

  • 중동 및 아프리카의 인크레틴 관련 의약품 시장 : 현황
  • 중동 및 아프리카의 인크레틴 관련 의약품 시장 : 시장 규모와 CAGR(2018년-2028년)
  • 중동 및 아프리카의 인크레틴 관련 의약품 시장 : 주요 요인
  • 중동 및 아프리카의 인크레틴 관련 의약품 시장 : 부문 분석
  • 중동 및 아프리카의 인크레틴 관련 의약품 시장 세분화 : 의약품 유형별
  • 중동 및 아프리카의 인크레틴 관련 의약품 시장 세분화 : 투여 경로별
  • 중동 및 아프리카의 인크레틴 관련 의약품 시장 세분화 : 적응증별

제9장 시장 역학

  • 세계의 인크레틴 관련 의약품 시장에 대한 시장 역학의 영향 평가
  • 성장 촉진요인
  • 성장 억제요인
  • 동향

제10장 Porter의 Five Forces 분석

제11장 경쟁 포지셔닝

  • 기업의 제품 포지셔닝
  • 시장 포지션 매트릭스
  • 인크레틴 관련 의약품 시장 점유율 분석
  • 기업 개요
    • Eli Lilly and Company
    • Boehringer Ingelheim
    • Novo Nordisk
    • AstraZeneca PLC
    • Merck & Co., Inc.
    • Pfizer
    • Novartis AG
    • Takeda Pharmaceuticals
    • Bristol Myers Squibb
    • Structure Therapeutics
LSH 23.12.13

Executive Summary

Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), By Route of Administration (Oral, Injectables) and By Indication (Diabetes, Obesity) for the historical period of 2018-2022, the estimated year of 2023 and the forecast period of 2024-2028.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.

During the forecast period, 2024-2029, the Global Incretin Based Drugs market is expected to grow at a CAGR of 6.8%. The Global Incretin Based Drugs Market is expected to generate USD 64.28 billion by the end of 2029, up from USD 40.72 Billion in 2022.

Incretin-based drugs are the first-of-its-kind anti-hyperglycemic medications that have been developed by specifically targeting a recognized pathophysiological abnormality in type 2 diabetes. The global increase in the prevalence of type 2 diabetes has a significant impact on the demand for incretin-based drugs. The growing incidence of diabetes can be attributed to various factors, including sedentary lifestyles, poor dietary habits, and the ageing demographic.

In comparison to many other anti-hyperglycemic medications, incretin-based drugs offer some notable benefits, including the lack of an elevated risk of hypoglycemia or weight gain. The DPP4Is and GLP-1RAs exhibit unique efficacy and tolerability profiles, providing physicians with the opportunity to choose the most suitable medication for each patient, taking into account factors such as disease status (as indicated by HbA1c percentage), body weight, and patient preference for self-administered injectable drugs. The demand for Incretin-based drugs is expected to grow exponentially as the blockbuster drugs in the market become accessible in generic form and as upgraded formulations with reduced dosing frequency are introduced.

Scope of the Report

  • The report analyses the Incretin Based Drugs Market by Value (USD Billion).
  • The report presents the analysis of Incretin Based Drugs Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
  • The report analyses the Incretin-Based Drugs Market by Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors).
  • The report analyses the Incretin Based Drugs Market by Route of Administration (Oral, Injectables)
  • The report analyses the Incretin-Based Drugs Market by Indication (Diabetes, Obesity).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Drug Type, By Route of Administration and by Indications.
  • Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk, AstraZeneca PLC, Merck & Co., Inc., Pfizer, Novartis AG, Takeda Pharmaceuticals, Bristol Myers Squibb, Structure Therapeutics.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Strategic Recommendations

3. Global Incretin Based Drugs Market: Historic and Forecast (2018-2028)

  • 3.1 Global Obesity Statistics 2022, in Millions
  • 3.2 Pipeline Analysis of Incretin based drugs
  • 3.3 Countries with the highest prevalence of diabetes worldwide in 2021
  • 3.4 Estimated number of individuals with Diabetes Worldwide, in thousands (2000-2014E)
  • 3.5 Global Incretin-Based Drugs Market: Dashboard
  • 3.6 Global Incretin Based Drugs Market: Market Value Assessment, 2018-2028 (USD Billion)
  • 3.7 Impact of COVID-19 on Global Incretin Based Drugs Market
  • 3.8 Global Incretin-Based Drugs Market Segmentation: By Drug Type
    • 3.8.1 Global Incretin-Based Drugs Market, By Drug Type Overview
    • 3.8.2 Global Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
    • 3.8.3 Global Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
  • 3.9 Global Incretin-Based Drugs Market Segmentation: By Route of Administration
    • 3.9.1 Global Incretin-Based Drugs Market, By Route of Administration Overview
    • 3.9.2 Global Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
    • 3.9.3 Global Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
  • 3.10 Global Incretin Based Drugs Market Segmentation: By Indication
    • 3.10.1 Global Incretin Based Drugs Market, By Indication Overview
    • 3.10.2 Global Incretin Based Drugs Market Size, By Diabetes By Value, 2018H-2028F (USD Billion & CAGR)
    • 3.10.3 Global Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)

4. Global Incretin Based Drugs Market, Region Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Incretin Based Drugs Market: Historic and Forecast (2018-2028)

  • 5.1 Americas Incretin-Based Drugs Market: Snapshot
  • 5.2 Americas Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  • 5.3 Americas Incretin-Based Drugs Market: Key Factors
  • 5.4 Americas Incretin-Based Drugs Market: Segment Analysis
  • 5.5 Americas Incretin-Based Drugs Market Segmentation: By Drug Type
    • 5.5.1 Americas Incretin-Based Drugs Market, By Drug Type Overview
    • 5.5.2 Americas Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
    • 5.5.3 Americas Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
  • 5.6 Americas Incretin-Based Drugs Market Segmentation: By Route of Administration
    • 5.6.1 Americas Incretin-Based Drugs Market, By Route of Administration Overview
    • 5.6.2 Americas Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
    • 5.6.3 Americas Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
  • 5.7 Americas Incretin-Based Drugs Market Segmentation: By Indication
    • 5.7.1 Americas Incretin-Based Drugs Market, By Indication Overview
    • 5.7.2 Americas Incretin-Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
    • 5.7.3 Americas Incretin-Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
  • 5.8 Americas Incretin-Based Drugs Market Segmentation: By Country
    • 5.8.1 United States Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 5.8.1.1 United States Incretin-Based Drugs Market, By Drug Type
      • 5.8.1.2 United States Incretin-Based Drugs Market, By Route of Administration
      • 5.8.1.3 United States Incretin-Based Drugs Market, By Indication
    • 5.8.2 Canada Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 5.8.2.1 Canada Incretin-Based Drugs Market, By Drug Type
      • 5.8.2.2 Canada Incretin-Based Drugs Market, By Route of Administration
      • 5.8.2.3 Canada Incretin-Based Drugs Market, By Indication
    • 5.8.3 Rest of Americas Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 5.8.3.1 Rest of Americas Incretin-Based Drugs Market, By Drug Type
      • 5.8.3.2 Rest of Americas Incretin-Based Drugs Market, By Route of Administration
      • 5.8.3.3 Rest of Americas Incretin-Based Drugs Market, By Indication

6. Europe Incretin Based Drugs Market: Historic and Forecast (2018-2028)

  • 6.1 Europe Incretin-Based Drugs Market: Snapshot
  • 6.2 Europe Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  • 6.3 Europe Incretin-Based Drugs Market: Key Factors
  • 6.4 Europe Incretin-Based Drugs Market: Segment Analysis
  • 6.5 Europe Incretin-Based Drugs Market Segmentation: By Drug Type
    • 6.5.1 Europe Incretin-Based Drugs Market, By Drug Type Overview
    • 6.5.2 Europe Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
    • 6.5.3 Europe Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
  • 6.6 Europe Incretin-Based Drugs Market Segmentation: By Route of Administration
    • 6.6.1 Europe Incretin-Based Drugs Market, By Route of Administration Overview
    • 6.6.2 Europe Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
    • 6.6.3 Europe Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
  • 6.7 Europe Incretin-Based Drugs Market Segmentation: By Indication
    • 6.7.1 Europe Incretin-Based Drugs Market, By Indication Overview
    • 6.7.2 Europe Incretin-Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
    • 6.7.3 Europe Incretin-Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
  • 6.8 Europe Incretin-Based Drugs Market Segmentation: By Country
    • 6.8.1 Germany Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 6.8.1.1 Germany Incretin-Based Drugs Market, By Drug Type
      • 6.8.1.2 Germany Incretin Based Drugs Market, By Route of Administration
      • 6.8.1.3 Germany Incretin Based Drugs Market, By Indication
    • 6.8.2 United Kingdom Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 6.8.2.1 United Kingdom Incretin Based Drugs Market, By Drug Type
      • 6.8.2.2 United Kingdom Incretin Based Drugs Market, By Route of Administration
      • 6.8.2.3 United Kingdom Incretin Based Drugs Market, By Indication
    • 6.8.3 France Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 6.8.3.1 France Incretin Based Drugs Market, By Drug Type
      • 6.8.3.2 France Incretin Based Drugs Market, By Route of Administration
      • 6.8.3.3 France Incretin Based Drugs Market, By Indication
    • 6.8.4 Italy Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 6.8.4.1 Italy Incretin Based Drugs Market, By Drug Type
      • 6.8.4.2 Italy Incretin Based Drugs Market, By Route of Administration
      • 6.8.4.3 Italy Incretin Based Drugs Market, By Indication
    • 6.8.5 Spain Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 6.8.5.1 Spain Incretin Based Drugs Market, By Drug Type
      • 6.8.5.2 Spain Incretin Based Drugs Market, By Route of Administration
      • 6.8.5.3 Spain Incretin Based Drugs Market, By Indication
    • 6.8.6 Rest of Europe Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 6.8.6.1 Rest of Europe Incretin-Based Drugs Market, By Drug Type
      • 6.8.6.2 Rest of Europe Incretin-Based Drugs Market, By Route of Administration
      • 6.8.6.3 Rest of Europe Incretin-Based Drugs Market, By Indication

7. Asia-Pacific Incretin Based Drugs Market: Historic and Forecast (2018-2028)

  • 7.1 Asia-Pacific Incretin Based Drugs Market: Snapshot
  • 7.2 Asia-Pacific Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  • 7.3 Asia-Pacific Incretin Based Drugs Market: Key Factors
  • 7.4 Asia-Pacific Incretin Based Drugs Market: Segment Analysis
  • 7.5 Asia-Pacific Incretin Based Drugs Market Segmentation: By Drug Type
    • 7.5.1 Asia-Pacific Incretin Based Drugs Market, By Drug Type Overview
    • 7.5.2 Asia-Pacific Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
    • 7.5.3 Asia-Pacific Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
  • 7.6 Asia-Pacific Incretin Based Drugs Market Segmentation: By Route of Administration
    • 7.6.1 Asia-Pacific Incretin Based Drugs Market, By Route of Administration Overview
    • 7.6.2 Asia-Pacific Incretin Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
    • 7.6.3 Asia-Pacific Incretin Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
  • 7.7 Asia-Pacific Incretin Based Drugs Market Segmentation: By Indication
    • 7.7.1 Asia-Pacific Incretin Based Drugs Market, By Indication Overview
    • 7.7.2 Asia-Pacific Incretin Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
    • 7.7.3 Asia-Pacific Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
  • 7.8 Asia-Pacific Incretin Based Drugs Market Segmentation: By Country
    • 7.8.1 China Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 7.8.1.1 China Incretin Based Drugs Market, By Drug Type
      • 7.8.1.2 China Incretin Based Drugs Market, By Route of Administration
      • 7.8.1.3 China Incretin Based Drugs Market, By Indication
    • 7.8.2 Japan Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 7.8.1.1 Japan Incretin Based Drugs Market, By Drug Type
      • 7.8.1.2 Japan Incretin Based Drugs Market, By Route of Administration
      • 7.8.1.3 Japan Incretin Based Drugs Market, By Indication
    • 7.8.3 India Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 7.8.3.1 India Incretin Based Drugs Market, By Drug Type
      • 7.8.3.2 India Incretin Based Drugs Market, By Route of Administration
      • 7.8.3.3 India Incretin Based Drugs Market, By Indication
    • 7.8.5 Rest of Asia-Pacific Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
      • 7.8.5.1 Rest of Asia-Pacific Incretin Based Drugs Market, By Drug Type
      • 7.8.5.2 Rest of Asia-Pacific Incretin Based Drugs Market, By Route of Administration
      • 7.8.5.3 Rest of Asia-Pacific Incretin Based Drugs Market, By Indication

8. Middle-East & Africa Incretin Based Drugs Market: Historic and Forecast (2018-2028)

  • 8.1 Middle-East & Africa Incretin Based Drugs Market: Snapshot
  • 8.2 Middle-East & Africa Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  • 8.3 Middle-East & Africa Incretin Based Drugs Market: Key Factors
  • 8.4 Middle-East & Africa Incretin Based Drugs Market: Segment Analysis
  • 8.5 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Drug Type
    • 8.5.1 Middle-East & Africa Incretin Based Drugs Market, By Drug Type Overview
    • 8.5.2 Middle-East & Africa Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
    • 8.5.3 Middle-East & Africa Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
  • 8.6 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Route of Administration
    • 8.6.1 Middle-East & Africa Incretin Based Drugs Market, By Route of Administration Overview
    • 8.6.2 Middle-East & Africa Incretin Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
    • 8.6.3 Middle-East & Africa Incretin Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
  • 8.7 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Indication
    • 8.7.1 Middle-East & Africa Incretin Based Drugs Market, By Indication: Overview
    • 8.7.2 Middle-East & Africa Incretin Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
    • 8.7.3 Middle-East & Africa Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)

9. Market Dynamics

  • 9.1 Impact Assessment of Market Dynamics on Global Incretin-Based Drugs Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Porter's Five Forces Analysis

  • 10.1 Porter's Five Forces Model

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Position Matrix
  • 11.3 Market Share Analysis of Incretin-Based Drugs Market
  • 11.4 Company Profiles
    • 11.4.1 Eli Lilly and Company
    • 11.4.2 Boehringer Ingelheim
    • 11.4.3 Novo Nordisk
    • 11.4.4 AstraZeneca PLC
    • 11.4.5 Merck & Co., Inc.
    • 11.4.6 Pfizer
    • 11.4.7 Novartis AG
    • 11.4.8 Takeda Pharmaceuticals
    • 11.4.9 Bristol Myers Squibb
    • 11.4.10 Structure Therapeutics
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제